[HTML][HTML] Non-ionic surfactants for stabilization of polymeric nanoparticles for biomedical uses

H Cortés, H Hernández-Parra, SA Bernal-Chávez… - Materials, 2021 - mdpi.com
Surfactants are essential in the manufacture of polymeric nanoparticles by emulsion
formation methods and to preserve the stability of carriers in liquid media. The deposition of …

Diverse applications of nanomedicine

B Pelaz, C Alexiou, RA Alvarez-Puebla, F Alves… - ACS …, 2017 - ACS Publications
The design and use of materials in the nanoscale size range for addressing medical and
health-related issues continues to receive increasing interest. Research in nanomedicine …

Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease

D Li, M Yang, H Xu, M Zhu, Y Zhang, C Tian… - Journal of Materials …, 2022 - pubs.rsc.org
As a group of chronic and idiopathic gastrointestinal (GI) disorders, inflammatory bowel
disease (IBD) is characterized by recurrent intestinal mucosal inflammation. Oral …

Advanced nanomedicines for the treatment of inflammatory diseases

R Brusini, M Varna, P Couvreur - Advanced drug delivery reviews, 2020 - Elsevier
Inflammation, a common feature of many diseases, is an essential immune response that
enables survival and maintains tissue homeostasis. However, in some conditions, the …

Oral delivery of nanoparticles loaded with ginger active compound, 6-shogaol, attenuates ulcerative colitis and promotes wound healing in a murine model of …

M Zhang, C Xu, D Liu, MK Han, L Wang… - Journal of Crohn's and …, 2018 - academic.oup.com
Abstract Background and Aims Oral drug delivery is the most attractive pathway for
ulcerative colitis [UC] therapy, since it has many advantages. However, this strategy has …

Bioresponsive drug delivery systems in intestinal inflammation: State-of-the-art and future perspectives

NG Kotla, S Rana, G Sivaraman, O Sunnapu… - Advanced drug delivery …, 2019 - Elsevier
Oral colon-specific delivery systems emerged as the main therapeutic cargos by making a
significant impact in the field of modern medicine for local drug delivery in intestinal …

Advances in the treatment of inflammatory bowel disease: Focus on polysaccharide nanoparticulate drug delivery systems

H Hadji, K Bouchemal - Advanced Drug Delivery Reviews, 2022 - Elsevier
The complex pathogenesis of inflammatory bowel disease (IBD) explains the several
hurdles for finding an efficient approach to cure it. Nowadays, therapeutic protocols aim to …

Surfactant-free, self-assembled nanomicelles-based transdermal hydrogel for safe and targeted delivery of methotrexate against rheumatoid arthritis

M Qindeel, D Khan, N Ahmed, S Khan… - ACS …, 2020 - ACS Publications
Methotrexate (MTX) is the first line agent for therapy against rheumatoid arthritis (RA);
however, orally its efficacy is hampered by poor solubility, less permeability, short plasma …

[HTML][HTML] Inflammation-specific targeted carriers for local drug delivery to inflammatory bowel disease

NG Kotla, R Singh, BV Baby, S Rasala, J Rasool… - Biomaterials, 2022 - Elsevier
Delivering drugs directly to the inflamed intestinal sites to treat inflammatory bowel disease
(IBD), particularly Crohn's and ulcerative colitis, is highly challenging. Recent advances in …

[HTML][HTML] Gut organoid as a new platform to study alginate and chitosan mediated PLGA nanoparticles for drug delivery

Z Davoudi, N Peroutka-Bigus, B Bellaire, A Jergens… - Marine drugs, 2021 - mdpi.com
Intestinal organoids can be used as an ex vivo epithelial model to study different drug
delivery effects on epithelial cells' luminal surface. In this study, the impact of surface charge …